Question 1

What are the most cited papers from OncoTab (United States)?

Accepted Answer

The most cited paper from OncoTab (United States) is "Preclinical evaluation of an 111In/225Ac theranostic targeting transformed MUC1 for triple negative breast cancer" (Vanessa J. Kelly, Shu-ta Wu, Gottumukkala Vijay et al., 2020), with 45 citations. Next come "A tumor specific antibody to aid breast cancer screening in women with dense breast tissue" (31) and "Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice" (22).

Question 2

Which research topics does OncoTab (United States) publish most on?

Accepted Answer

By volume: Glycosylation and Glycoproteins Research, Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.

Question 3

Which fields of science does OncoTab (United States) work in?

Accepted Answer

In all years, 57% of research at OncoTab (United States) is in Life Sciences, 43% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (52%), Medicine (43%), Immunology and Microbiology (5%). It does 1.5× the world's share of Life Sciences.

Question 4

Is OncoTab (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.